Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
3 No-Brainer Stocks to Buy in May
06:55am, Sunday, 05'th May 2024
It's always a good time to buy shares of Eli Lilly. Pfizer is undervalued and underrated.
Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
06:45am, Saturday, 04'th May 2024
The outlook for Pfizer's experimental obesity drug danuglipron is murky at best. Pfizer could pick up another obesity drug via an acquisition, but management says a near-term deal is unlikely.
3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade
05:17am, Saturday, 04'th May 2024
Above-average utilization of health benefits pressured CVS Health's bottom line, but this is a temporary problem. Ares Capital is a business development company that offers a huge dividend yield at re
Here's Why Pfizer (PFE) is a Strong Momentum Stock
10:56am, Friday, 03'rd May 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Dividend Harvesting Portfolio Week 165: $16,500 Allocated, $1,478.71 In Projected Dividends
09:00am, Thursday, 02'nd May 2024
Tesla's Q1 2024 earnings led to a jump in shares, while Meta Platforms experienced a significant drawdown.
My Top 5 Favorite High-Yield Dividend Stocks to Buy in May
05:50am, Thursday, 02'nd May 2024
These stocks offer exceptional dividend yields ranging from nearly 4% to over 9%. Several have impressive track records of dividend increases.
Pfizer's Stock Is a Buy. Here Are Six Reasons Why.
05:15am, Thursday, 02'nd May 2024
Pfizer may be one of the biggest bargains in the market today. The drugmaker offers an attractive yield, a rock-bottom valuation, and an underappreciated cancer pipeline.
Why Pfizer Stock Blasted More Than 6% Higher Today
05:55pm, Wednesday, 01'st May 2024
The pharmaceutical giant published its first-quarter results.
Pfizer Stock Gets Boost From Better-Than-Expected Earnings
01:46pm, Wednesday, 01'st May 2024
Pfizer (PFE) shares rose Wednesday after first-quarter earnings and revenue fell less than expected, with the decline partially offset by sales growth in the company's non-COVID-related products.
Pfizer (PFE) Q1 Earnings & Sales Top, EPS Guidance Raised
12:46pm, Wednesday, 01'st May 2024
Pfizer (PFE) beats first-quarter estimates for earnings and sales. It raises 2024 earnings guidance while retaining revenue expectations.
Pfizer (PFE) Reports Q1 Earnings: What Key Metrics Have to Say
10:35am, Wednesday, 01'st May 2024
While the top- and bottom-line numbers for Pfizer (PFE) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to
Pfizer revenues fall 19% due to lower COVID-related product demand
08:14am, Wednesday, 01'st May 2024
US pharmaceutical multinational Pfizer Inc (NYSE:PFE, ETR:PFE)'s first-quarter 2024 revenues stood at $14.9 billion, reflecting a 19% operational decline year over year, primarily due to decreased rev
Pfizer beats revenue estimates, raises profit outlook on cost cuts and strong non-Covid sales
07:13am, Wednesday, 01'st May 2024
The results come as Pfizer tries to regain its footing after the rapid decline of its Covid business.
Pfizer first-quarter results top estimates, drugmaker boosts full-year profit outlook
07:04am, Wednesday, 01'st May 2024
Pfizer Inc. shares PFE, -0.08% gained 1.5% premarket on Wednesday after the company reported first-quarter profit and sales that beat analyst expectations, boosted by strong sales of its Vyndaqel fami
Pfizer's 44% Decline In Profits Still Tops Estimates—Stock Bounces From Decade Low
07:02am, Wednesday, 01'st May 2024
Pfizer comfortably beat expectations in its quarterly earnings report Wednesday morning, as the American pharmaceutical giant attempts to regain its footing as the COVID-19 pandemic subsides.
